Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lublin
Clinical trial register · Poland

Clinical Trials in Lublin, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2711 matching records held by the registry are in this view. Synced 31 Oct 2026, 03:19 UTC
2711
Studies in scope
all four open statuses
1388
Recruiting now
open to new participants
513
Lead sponsors
across recruiting studies
Top sites
Warsaw 61 Krakow 42 Bydgoszcz 36 Lublin 30 Gda?sk 28
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca44 Janssen Research & Development, LLC36 Hoffmann-La Roche30 Novo Nordisk A/S18 Eli Lilly and Company17 Clear sponsor filter
Site location
Warsaw61 Krakow42 Bydgoszcz36 Lublin30 Gda?sk28
All 79 locations
Target enrolment
to

Trials with a site in Lublin

30 of 2711 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Hoffmann-La Roche
Phase 1
25
Bydgoszcz, Lodz, Lublin, Nowy Targ, Pabianice, Późna, Warsaw, Wroc?aw
2026-06-29
Recruiting
Hoffmann-La Roche
Phase 2
120
Warsaw, Bytom, Elblag, Lublin, Nowa Sól, Wroclaw
2026-06-03
Recruiting
Hoffmann-La Roche
Phase 2
80
?ód?, Bialystok, Lublin, Wroc?aw
2026-04-07
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Bialystok, Bydgoszcz, Dębica, Lublin, Pabianice, Poznan, Ruda Śląska, Siedlce
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Bialystok, Bydgoszcz, Gdynia, Krakow, Lublin, Opole, Tarnów, Tychy
2026-03-16
Recruiting
Hoffmann-La Roche
Phase 2
160
Bytom, Elbl?g, Krakow, Lublin, Nowa Sól, Warsaw, Wroclaw
2025-12-05
Recruiting
Hoffmann-La Roche
Phase 3
250
Krakow, Bielsko-Biala, Bydgoszcz, Gliwice, Lódz, Lublin, Olsztyn
2025-11-27
Recruiting
Hoffmann-La Roche
Phase 3
900
Bia?ystok, Bydgoszcz, Gda?sk, Katowice, Krakow, Lublin, Oświęcim, Rzeszów
2025-11-24
Recruiting
Hoffmann-La Roche
Phase 3
600
Bystra, Gda?sk, Krakow, Lublin, Olsztyn, Poznan, Radom, Warsaw
2025-10-24
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Bydgoszcz, Katowice, Krakow, Lublin, Rzeszów, Warsaw, Wroc?aw, Zabrze
2025-09-17
Active, closed
Hoffmann-La Roche
Phase 2
330
Bialystok, Gdansk, Bydgoszcz, Katowice, Lublin, Tarnów, Warsaw, Wroclaw
2025-08-19
Recruiting
Hoffmann-La Roche
Observational
700
Krakow, Lublin, Olsztyn, Poznan, Słupsk, Tomaszów Mazowiecki
2025-07-15
Recruiting
Hoffmann-La Roche
Phase 3
425
Bia?ystok, Bydgoszcz, Elblag, I?awa, Knurów, Krakow, Lodz, Lublin
2025-05-12
Active, closed
Hoffmann-La Roche
Phase 2
285
Krakow, Gdansk, Lublin, Warsaw
2025-05-05
Recruiting
Hoffmann-La Roche
Not applicable
270
Gdansk, Krakow, Kraśnik, Lublin, Nadarzyn, Warsaw
2025-04-14
Recruiting
Hoffmann-La Roche
Phase 3
450
?ód?, Bialystok, Konin, Koszalin, Krakow, Lublin, Późna, Rzeszów
2025-04-09
Active, closed
Hoffmann-La Roche
Phase 3
350
?ód?, Bydgoszcz, Elblag, I?awa, Knurów, Krakow, Lublin, Poznan
2024-12-11
Active, closed
Hoffmann-La Roche
Phase 3
1,050
?ód?, Bydgoszcz, Gdynia, Gliwice, Kielce, Konin, Koszalin, Lublin
2023-12-11
Active, closed
Hoffmann-La Roche
Phase 3
1,300
Bydgoszcz, Gda?sk, Katowice, Krakow, Lodz, Lublin, Olsztyn, Plewiska
2022-05-03
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Bydgoszcz, Gdynia, Gliwice, Grudziądz, Krakow, Lodz, Lublin, Poznan
2021-08-27
Active, closed
Hoffmann-La Roche
Phase 2
586
?ód?, Bydgoszcz, Gda?sk, Krakow, Lublin, Rzeszów, Warsaw
2021-05-05
Active, closed
Hoffmann-La Roche
Phase 3
746
?ory, Bydgoszcz, Katowice, Krosno, Lodz, Lublin, Warsaw, Zabrze
2021-03-17
Active, closed
Hoffmann-La Roche
Phase 3
270
Gdansk, Lublin, Olsztyn, Warsaw, Wroc?aw
2021-02-23
Active, closed
Hoffmann-La Roche
Phase 3
769
Bydgoszcz, Gdansk, Katowice, Krakow, Lodz, Lublin, Oświęcim, Plewiska
2020-12-03
Active, closed
Hoffmann-La Roche
Phase 3
864
Bydgoszcz, Gdansk, Katowice, Lodz, Lublin, Późna, Rzeszów, Szczecin
2020-11-26
Active, closed
Hoffmann-La Roche
Phase 3
210
Bydgoszcz, Gdansk, Lublin, Skórzewo, Warsaw
2020-10-08
Active, closed
Hoffmann-La Roche
Phase 3
190
Bydgoszcz, Gda?sk, Lublin, Skórzewo, Warsaw
2020-09-30
Active, closed
Hoffmann-La Roche
Phase 3
271
Lublin, Poznan, Warsaw, Wroclaw
2020-08-10
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Bydgoszcz, Wroclaw, Lublin, Rzeszów, Rybnik, Bia?ystok, Gda?sk, Grodzisk Mazowiecki
2019-08-12
Active, closed
Hoffmann-La Roche
Phase 3
154
Lublin
2015-02-02
Rows per page Showing 1–30 of 30
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 1 November 2026. https://priyalifescience.com/clinical-trials-poland/city/lublin

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,711 studies in total at the last sync on 31 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 30 of those studies with a site in Lublin that also match the filters currently applied.

How many clinical trials are recruiting in Lublin?

13 of the 30 studies on this page are recruiting new participants as of the 31 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 17 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lublin), 30 studies
PhaseStudiesRecruitingShare
Phase 321770%
Phase 26320%
Not applicable113.3%
Observational113.3%
Phase 1113.3%

Most active sponsors

Lead sponsors with the most studies (Lublin)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche3013
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.